RepliCel Life Sciences Dividend
Dividend criteriumcontroles 0/6
RepliCel Life Sciences does not have a record of paying a dividend.
Belangrijke informatie
n/a
Dividendrendement
375,740.5%
Terugkoop Rendement
Totaal aandeelhoudersrendement | 375,740.5% |
Toekomstig dividendrendement | n/a |
Dividendgroei | n/a |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | n/a |
Uitbetalingsratio | n/a |
Recente dividendupdates
Geen updates
Recent updates
Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if REPC.F's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if REPC.F's dividend payments have been increasing.
Dividendrendement versus markt
RepliCel Life Sciences Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (REPC.F) | n/a |
Markt onderkant 25% (US) | 1.5% |
Markt Top 25% (US) | 4.5% |
Gemiddelde industrie (Life Sciences) | 0.5% |
Analist prognose (REPC.F) (tot 3 jaar) | n/a |
Opmerkelijk dividend: Unable to evaluate REPC.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate REPC.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate REPC.F's payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as REPC.F has not reported any payouts.